CG
LUMO

Cutler Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Cutler Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,744
Closed -$45K – 6142
2017
Q3 		$45K Buy
11,744
+6,266
+114% +$481K ﹤0.01% 2347
2017
Q2 		$12K Sell
5,478
-1,189
-18% -$147K ﹤0.01% 4005
2017
Q1 		$362K Sell
6,667
-1,700
-20% -$243K 0.02% 809
2016
Q4 		$19K Sell
8,367
-1,089
-12% -$123K ﹤0.01% 3528
2016
Q3 		$70K Sell
9,456
-2,455
-21% -$244K ﹤0.01% 2142
2016
Q2 		$46K Buy
11,911
+3,867
+48% +$479K ﹤0.01% 2448
2016
Q1 		$185K Sell
8,044
-2,356
-23% -$478K 0.01% 1066
2015
Q4 		$500K Buy
+10,400
New +$3.39M 0.03% 606

Other funds holding LUMO

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's LUMO Position: Q4 2019 in Review

Cutler Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 167 shares — an estimated $2K sold.

Cutler Group first reported a position in LUMO in Q4 2015 and held it in 16 quarters. The position peaked at $1.23M in Q4 2015. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Cutler Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Cutler Group sold 167 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $2K.
  • Cutler Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Lumos Pharma, Inc. Common Stock position peaked at $1.23M in Q4 2015.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.